Hua-Tao Wu

1.2k citations
38 papers · 846 indexed · h-index 15
Topics
Cancer-related molecular mechanisms research (9 papers)RNA modifications and cancer (8 papers)Ferroptosis and cancer prognosis (5 papers)
Partner nations
China

In The Last Decade

Hua-Tao Wu

36 papers receiving 833 citations

Peers

Hua-Tao Wu
Comparison fields: 5 of 87
  • Molecular Biology 476
  • Cancer Research 242
  • Oncology 221
  • Pulmonary and Respiratory Medicine 147
  • Immunology 73
Replace Rareş Drulă with:
Rareş Drulă Romania
Zitong Zhao China
Sreedevi Avasarala United States
Wenguang Wu China
Dianbo Yao China
Călin Ionescu Romania
Zhirong Jia China
Constantin Busuioc Romania
Zhenling Liu China
Hua-Tao Wu relative to Rareş Drulă Romania Rareş Drulă's profile →
Citations per field
00.5×10×20×30×36×
Rareş Drulă · 1×
Citations per year

Countries citing papers authored by Hua-Tao Wu

Since Specialization
Citations

This map shows the geographic impact of Hua-Tao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua-Tao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua-Tao Wu more than expected).

Fields of papers citing papers by Hua-Tao Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hua-Tao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua-Tao Wu. The network helps show where Hua-Tao Wu may publish in the future.

Co-authorship network of co-authors of Hua-Tao Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Hua-Tao Wu. A scholar is included among the top collaborators of Hua-Tao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua-Tao Wu. Hua-Tao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 2
4 1
5 1
6 3
7 16
8 8
9 29
10 6
11 5
12 4
13 24
14 19
15 33
16 29
17 53
18 11
19
Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target.
181
20 75

About Hua-Tao Wu

Hua-Tao Wu is a scholar working on Cancer Research, Oncology and Applied Microbiology and Biotechnology, having authored 38 papers that have together received 846 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (8 papers) and Ferroptosis and cancer prognosis (5 papers). The work is most often cited by research in Cancer Research (242 citations), Oncology (221 citations) and Pharmacology (65 citations). Hua-Tao Wu has collaborated with scholars based in China. Frequent co-authors include Wen-Jia Chen, Jing Liu, Guo‐Jun Zhang, Manli Zhang, Jiaxin Shen, Jing Liu, Qianqian Ye, Ying‐Kai Hong, Tao Ma and Guanwu Li. Their work appears in journals such as International Journal of Biological Macromolecules, World Journal of Gastroenterology and BioMed Research International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026